Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
17 studies found for:    Open Studies | "Nail Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Nail Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Trial of Evonail® Solution for Prevention or Treatment of Onycholysis
Conditions: Breast Cancer;   Docetaxel Chemotherapy
Intervention: Drug: EVONAIL® solution
2 Not yet recruiting Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis
Condition: Onychomycosis
Interventions: Device: Nailner 2 in 1;   Drug: Ciclopirox 8%
3 Recruiting Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study
Condition: Onychomycosis
Interventions: Drug: NVXT topical;   Drug: Placebo (Vehicle) Topical
4 Recruiting Study to Evaluate the Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
Condition: Distal Subungual Onychomycosis
Interventions: Drug: MOB015B;   Drug: Ciclopirox 80 mg/g
5 Recruiting A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
Condition: Distal Subungual Onychomycosis
Interventions: Drug: MOB015B;   Drug: MOB015B Vehicle
6 Recruiting Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
Condition: Onychomycosis
Intervention: Drug: Efinaconazole
7 Recruiting Comparison Between Long-pulsed Nd:YAG, Amorolfine and Combination Treatment in Treating Non-dermatophyte Onychomycosis
Condition: Non-dermatophyte Onychomycosis
Interventions: Device: 1,064nm Long-pulsed Nd:YAG;   Drug: Amorolfine
8 Recruiting Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Mild to Moderate Toenail Fungus of the Big Toenail
Condition: Onychomycosis
Intervention: Drug: HTS-519 Insert
9 Recruiting Evaluating the Safety, Tolerability and Preliminary Efficacy of Plasma in Improving the Appearance of Onychomycosis
Condition: Onychomycosis
Interventions: Device: MOE Plasma Delivery System A;   Device: MOE Plasma Delivery System B
10 Recruiting The Efficacy of CELEXT07 in the Treatment of Toenail Onychomycosis
Condition: Onychomycosis
Interventions: Drug: CELEXT07;   Drug: Penlac;   Other: vehicle solution
11 Recruiting Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail Onychomycosis
Condition: Onychomycosis
Interventions: Drug: P-3058 10%;   Drug: vehicle of P-3058 10%;   Drug: amorolfine 5%
12 Recruiting Clinical Trial on Onychomycosis With P-3058 Nail Solution in Pediatric Population
Condition: Onychomycosis
Intervention: Drug: P-3058
13 Recruiting Evaluation of the Efficacy of CURE-EX Treatment in Onychomycosis
Condition: Onychomycosis
Intervention: Device: CURE-EX device
14 Recruiting Evaluation of the Suitability of PD P 506 A in the PDT of Distal Subungual Onychomycosis (DSO) of the Great Toenail.
Condition: Onychomycosis
Intervention: Drug: PD P 506 A
15 Recruiting Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
Conditions: Epidermolysis Bullosa Simplex;   Pachyonychia Congenita
Interventions: Drug: Jojoba oil with broccoli sprout extract;   Drug: Jojoba oil (placebo)
16 Recruiting International Pachyonychia Congenita Research Registry
Condition: Pachyonychia Congenita
Intervention:
17 Not yet recruiting Laser Treatment for Onychomycosis in Diabetes
Conditions: Diabetes Mellitus, Type 2;   Onychomycosis
Interventions: Device: Laser Treatment YAG laser;   Drug: Standard Treatment (control group) terbinafine hydrochloride tablets

Study has passed its completion date and status has not been verified in more than two years.